Welcome - CNS - Validated tests an QA
Founded in 1996 - CNS focus - Validated tests - Quality - Customers - Publications
Therapeutic area - Methods - Disease Models - Programs - Research Collaboration Contract Research - Research Partner - Research Collaboration - QA Program - Confidentiality and IP Rights Sign-up for mailing list - Examples of newsletters Contact us
Search engine
PRECLINICAL RESEARCH
MODEL OF CHEMOTHERAPY-INDUCED NEUROPATHY USING
CO-CULTURE OF SENSORY NEURONS AND SCHWANN CELLS
PDF file
Introduction
Compound testing
Cisplatine, vincristine and taxol are widely used as antimitotic drugs for treating various cancers. However, their employment is often limited by their neurotoxicity (Quasthoff et Hartung, 2002). Counteracting this side effect without affecting their anti-cancer activities is a promising developmental strategy.
Co-cultures from sensory neurons and Schwann cells are injured by anti-chemotherapeutic drugs (cisplatine 0.5 µg/ml, vincristine 1 ng/ml or taxol 0.5 µg/ml). The aim of this study is to investigate the putative protective effect of tested compounds on this damage. Global cellular survival is assessed by measuring acid phosphatase activity after 48h exposure to injured drug and tested compound.


Cisplatine induces cell death in sensory neurons in a dose dependant manner.
At each dose tested, NGF at 5 ng/ml is able to protect neurons against ciplatine damage.
Taxol induces sensory neuron cell death.
NGF is able to protect sensory neurons against this injury.

Vincristine induces cell death in sensory neurons in a dose dependant manner.
At each dose tested, NGF at 5 ng/ml is able to protect neurons against the vincristine damage.
References
Quatschoff S. and Hartung H.P. Chemotheray-induced peripheral neuropathy. (2002). J. Neurol. 249:9-17.